BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33964300)

  • 1. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
    Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
    J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen signaling negatively controls group 2 innate lymphoid cells.
    Laffont S; Blanquart E; Savignac M; Cénac C; Laverny G; Metzger D; Girard JP; Belz GT; Pelletier L; Seillet C; Guéry JC
    J Exp Med; 2017 Jun; 214(6):1581-1592. PubMed ID: 28484078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
    Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
    Front Immunol; 2021; 12():664218. PubMed ID: 34867937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Major Population of Functional KLRG1
    Kadel S; Ainsua-Enrich E; Hatipoglu I; Turner S; Singh S; Khan S; Kovats S
    Immunohorizons; 2018 Feb; 2(2):74-86. PubMed ID: 29568816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity.
    Helou DG; Shafiei-Jahani P; Hurrell BP; Painter JD; Quach C; Howard E; Akbari O
    J Allergy Clin Immunol; 2022 Jan; 149(1):223-236.e6. PubMed ID: 34144112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prostaglandin D
    Oyesola OO; Duque C; Huang LC; Larson EM; Früh SP; Webb LM; Peng SA; Tait Wojno ED
    J Immunol; 2020 Feb; 204(4):1001-1011. PubMed ID: 31900341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-Protein Inhibition in ILC2 Development Shapes the Function of Mature ILC2s during Allergic Airway Inflammation.
    Barshad G; Webb LM; Ting HA; Oyesola OO; Onyekwere OG; Lewis JJ; Rice EJ; Matheson MK; Sun XH; von Moltke J; Danko CG; Tait Wojno ED
    J Immunol; 2022 Mar; 208(5):1007-1020. PubMed ID: 35181641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation.
    Roediger B; Kyle R; Tay SS; Mitchell AJ; Bolton HA; Guy TV; Tan SY; Forbes-Blom E; Tong PL; Köller Y; Shklovskaya E; Iwashima M; McCoy KD; Le Gros G; Fazekas de St Groth B; Weninger W
    J Allergy Clin Immunol; 2015 Dec; 136(6):1653-1663.e7. PubMed ID: 26025126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
    Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
    Symowski C; Voehringer D
    Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
    Hurrell BP; Helou DG; Shafiei-Jahani P; Howard E; Painter JD; Quach C; Akbari O
    J Allergy Clin Immunol; 2022 May; 149(5):1628-1642.e10. PubMed ID: 34673048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
    Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
    Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex differences exist in adult heart group 2 innate lymphoid cells.
    Peng H; Wu S; Wang S; Yang Q; Wang L; Zhang S; Huang M; Li Y; Xiong P; Zhang Z; Cai Y; Li L; Deng Y; Deng Y
    BMC Immunol; 2022 Oct; 23(1):52. PubMed ID: 36316644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17-producing ST2
    Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
    J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in group 2 innate lymphoid cell-dominant allergic airway inflammation.
    Wang C; Xu ZB; Peng YQ; Zhang HY; Yu QN; Guo YB; Tan WP; Liu YL; Meng XC; Fang SB; Chen D; Fu QL
    Mol Immunol; 2020 Dec; 128():89-97. PubMed ID: 33096416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids and Androgens Protect From Gastric Metaplasia by Suppressing Group 2 Innate Lymphoid Cell Activation.
    Busada JT; Peterson KN; Khadka S; Xu X; Oakley RH; Cook DN; Cidlowski JA
    Gastroenterology; 2021 Aug; 161(2):637-652.e4. PubMed ID: 33971182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Rel Is Required for IL-33-Dependent Activation of ILC2s.
    Zaini A; Fulford TS; Grumont RJ; Runting J; Rodrigues G; Ng J; Gerondakis S; Zaph C; Scheer S
    Front Immunol; 2021; 12():667922. PubMed ID: 34194431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous oxidative stress suppresses IL-33 -driven proliferation programming in group 2 innate lymphoid cells.
    Zheng C; Lu Z; Wu H; Cui L; Bi J; Wan X
    Int Immunopharmacol; 2021 Jun; 95():107541. PubMed ID: 33756232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation through toll-like receptor 2 on group 2 innate lymphoid cells can induce asthmatic characteristics.
    Ishii T; Muroi M; Horiguchi K; Tanamoto KI; Nagase T; Yamashita N
    Clin Exp Allergy; 2019 Dec; 49(12):1624-1632. PubMed ID: 31494992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses.
    Zhou W; Toki S; Zhang J; Goleniewksa K; Newcomb DC; Cephus JY; Dulek DE; Bloodworth MH; Stier MT; Polosuhkin V; Gangula RD; Mallal SA; Broide DH; Peebles RS
    Am J Respir Crit Care Med; 2016 Jan; 193(1):31-42. PubMed ID: 26378386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.